Skip to main content
Clinical Trials/NCT02851160
NCT02851160CompletedNot Applicable

Perceptions and Representations of Cancer Chemotherapy

University Hospital, Montpellier0 sites75 target enrollmentStarted: March 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
75
Primary Endpoint
The semi-structured interview

Study Overview

Brief Summary

Qualitative study on data from interviews such patients, relatives and doctors involved in the implementation of cancer care. Framework type of method using grounded theory

Detailed Description

The word chemotherapy itself, because it belongs to the secular knowledge and therefore Doxa is a hard word, which stores what it is stable, common and therefore impersonal. It has the properties of a symbol, that is to say that joint several meanings, some of which are contradictory.

The objective of the research:

To determine the perceptions and representations of chemotherapy, its physical impacts, psychological and relational.

To qualitatively compare the performances of chemotherapy as it has an end as scheduled for adjuvant chemotherapy, or endless precise as in the palliative chemotherapy

Study Design

Study Type
Observational
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 30 major Patients with lung cancer requiring chemotherapy either as palliative or adjuvant as surgical treatment
  • 30 significant others (relatives) major applicant lung cancer patients chemotherapy either palliation or as adjuvant to surgery
  • 15 Doctors oncologists performing either chemotherapy as palliative or adjuvant as surgical treatment

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The semi-structured interview

Time Frame: 1 day (day of inclusion)

The interview will be analyzed in a framework type of method (grounded theory) in accordance with the guidelines coreq.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials